• Order to parcel locker

    Order to parcel locker
  • easy pay

    easy pay
  • Reduced price
Ovarian Cancer Immunotherapy

Ovarian Cancer Immunotherapy

9780190248208
807.30 zł
726.57 zł Save 80.73 zł Tax included
Lowest price within 30 days before promotion: 726.57 zł
Quantity
Available in 4-6 weeks

  Delivery policy

Choose Paczkomat Inpost, Orlen Paczka, DPD or Poczta Polska. Click for more details

  Security policy

Pay with a quick bank transfer, payment card or cash on delivery. Click for more details

  Return policy

If you are a consumer, you can return the goods within 14 days. Click for more details

Description
Ovarian Cancer Immunotherapy provides a broad overview of several aspects of basic sciences, and clinical and therapeutic aspects of immunotherapy for ovarian cancer, as well as state-of-the-art information on molecular genetics and biology. Chapters are written by a team of expert contributors from around the world and explore topics such as antibody therapeutics for ovarian carcinoma, emerging serum biomarkers, ovarian cancer immunity, adoptive cell immunotherapy, thebiology of dendritic cells, the role of growth factors, and more. Readers will also gain a better understanding of the molecular and cellular events that underlie ovarian cancer immunology. This book is an ideal resource for clinicians, basic medical scientists, graduate basic medical science students, andmedical students caring for patients with ovarian cancer, including attending surgeons and physicians, and clinical fellows and residents in the disciplines of gynecologic oncology, medical oncology, and surgical oncology.
Product Details
OUP USA
87926
9780190248208
9780190248208

Data sheet

Publication date
2018
Issue number
1
Cover
hard cover
Pages count
272
Dimensions (mm)
178 x 254
Weight (g)
757
  • Chapter 1: Antibody Therapeutics for Ovarian Carcinoma and Translation to the Clinic; Debra H. Josephs, Heather J. Bax, Giulia Pellizzari, James F. Spicer, Ana Montes, and Sophia N. Karagiannis; Chapter 2: Biological Aspects and Clinical Applications of Serum Biomarkers in Ovarian Cancer; Rouba Ali- Fehmi and Eman Abdulfatah; Chapter 3: Ovarian Cancer Immunity: How Does Immune Suppression Grow Cancer?; Vincent Lavoue, Patrick Legembre, Jean Lev?que, Fabrice Foucher, Sebastien Henno, and Florian Cabillic; Chapter 4: Ovarian Tumor Microenvironment and Innate Immune Recognition; Jocelyn Reader, Sarah Lynam, Amy Harper, Gautam Rao, Maya Matheny, and Dana M. Roque; Chapter 5: Adoptive Cell Immunotherapy for Epithelial Ovarian Cancer; Samir A. Farghaly; Chapter 6: Antibody-based Therapy for Ovarian Cancer; Yousef Alharbi, Manish S. Patankar, and Rebecca J. Whelan; Chapter 7: Epitope/Peptide-based Monoclonal Antibodies for Immunotherapy of Ovarian Cancer; Gregory Lee; Chapter 8: Dendritic Cell Vaccine Therapy for Ovarian Cancer; Caitlin Stashwick, Brian J. Czerniecki, Janos L. Tanyi; Chapter 9: Heat Shock Protein Vaccine Therapy for Ovarian Cancer; Hiroyuki Abe, Amane Sasada, Shigeki Tabata, and Minako Abe; Chapter 10: PD-1 /PDL-1 Inhibitors as Immunotherapy for Ovarian Cancer; Scott Moerdler and Xingxing Zang; Chapter 11: Growth Factors and Their Corresponding Receptors as Targets for Ovarian Cancer Therapy; Anca Maria Cimpean, Andreea Adriana Jitariu, and Marius Raica; Chapter 12: Unique Challenges Facing Immunotherapy of Metastatic Ovarian Cancer; Michelle N. Messmer, Colleen S. Netherby, and Scott I. Abrams; Chapter 13: Clinical Trials of Ovarian Cancer Immunotherapy and Future Directions; Justin M. Drerup, Curtis A. Clark, and Tyler J. Curiel;
Comments (0)